Skip to main content
QTI
NASDAQ Industrial Applications And Services

QT Imaging Reports 103% Q2 Revenue Growth, Reaffirms Guidance, and Expands Operations

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.88
Mkt Cap
$41.444M
52W Low
$2.51
52W High
$9.209
52W Position info
15% above low
Off High info
69% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

QTI is trading near its 52-week low of $2.51 (15% above the low).

Summary

QT Imaging Holdings announced robust Q2 2026 financial results with significant revenue growth and reaffirmed full-year guidance, alongside key operational and regulatory advancements.

Updates

  1. · SEC 10-Q — Q2 net loss was $11.1M, including an $8.3M loss on debt extinguishment and modification; six-month net loss was $14.5M. Cash and equivalents were $10.9M at June 30, 2026.


Key Events · Earnings and Guidance · QTI

  • Strong Q2 Revenue Growth

    Revenue increased 103% year-over-year to $7.4 million for Q2 2026, with 15 Breast Acoustic CT scanners shipped. First-half revenue grew 116% to $14.0 million.

  • Reaffirmed Full-Year Guidance

    The company reiterated its full-year 2026 revenue guidance of approximately $39 million.

  • Debt Maturity Extended

    The senior secured term loan maturity was extended by two years to March 2029, though at a higher interest rate (10% to 12%). This resulted in an $8.3 million non-cash loss on debt extinguishment.

  • Operational Milestones Achieved

    QT Imaging completed a successful FDA inspection with zero Form 483 observations, expanded manufacturing capacity with a new 22,000 sq ft facility, and secured regulatory authorizations in Israel and Saudi Arabia.


Analysis · QTI · Industrial Applications And Services

QT Imaging Holdings reported strong Q2 2026 revenue growth of 103% year-over-year to $7.4 million, driven by increased scanner shipments. The company reaffirmed its full-year 2026 revenue guidance of $39 million. While net loss increased due to a non-cash debt extinguishment charge, the company achieved significant operational milestones including a successful FDA inspection, expanded manufacturing, and new international regulatory approvals, which are critical for commercial scale-up.

How filings like this one have moved

In the 30 days to Oct 2, 2026, 36.3% of the 1072 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, QTI was trading at $2.88 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $41.4M. The 52-week trading range was $2.51 to $9.21. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QTI - Latest Insights

QTI
Aug 18, 2026, 8:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.75
Real-time Price: $2.53 info
Change: -$0.220 (-8%) info
Market Cap: $37.03M info
QTI
Aug 12, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.03
Real-time Price: $2.53 info
Change: -$0.500 (-17%) info
Market Cap: $37.03M info
QTI
Aug 12, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.88
Real-time Price: $2.53 info
Change: -$0.350 (-12%) info
Market Cap: $37.03M info
QTI
Jun 22, 2026, 4:59 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $3.77
Real-time Price: $2.53 info
Change: -$1.24 (-33%) info
Market Cap: $37.03M info
QTI
May 21, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.04
Real-time Price: $2.53 info
Change: -$2.51 (-50%) info
Market Cap: $37.03M info